Showing results (291-300 of 7,002) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|November 10, 2019
Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathwaysAugusto Caraceni, Silvia Lo Dico, Ernesto Zecca, et al.
Lung Cancer (Amsterdam, Netherlands)|November 10, 2019
Hyper-progressive disease in a patient with advanced non-small cell lung cancer on immune checkpoint inhibitor therapy: A case report and literature reviewDongxiao Zhang, Yan Zhang, Yong Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 12, 2019
Impact of coexisting gene mutations in EGFR-mutated non-small cell lung cancer before treatment on EGFR T790M mutation status after EGFR-TKIsMasayuki Takeda, Kazuko Sakai, Hidetoshi Hayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2019
Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decisionA C Sousa, C Silveira, A Janeiro, et al.
Lung Cancer (Amsterdam, Netherlands)|December 10, 2019
Trends in lung cancer risk and screening eligibility affect overdiagnosis estimatesErik F Blom, Kevin Ten Haaf, Harry J de Koning
Lung Cancer (Amsterdam, Netherlands)|February 17, 2020
Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicityAsal M Johnson, Allen Johnson, Robert B Hines, et al.
Lung Cancer (Amsterdam, Netherlands)|February 18, 2020
Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer1Jee Won Suh, Yong Hyu Jeong, Arthur Cho, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2020
Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysisMasaoki Ito, Yoshihiro Miyata, Yasuhiro Tsutani, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2020
A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancerMarliese Alexander, Nick Pavlakis, Thomas John, et al.
Lung Cancer (Amsterdam, Netherlands)|February 24, 2020
ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKIOscar S H Chan, Kwok Chi Lam, Jacky Y C Li, et al.
Pageof 701